David Shaw’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$150M Buy
4,319,800
+3,552,300
+463% +$95.4M 0.07% 290
2026
Q1
$15.9M Sell
767,500
-2,281,000
-75% -$53.9M 0.01% 1294
2025
Q4
$99M Buy
3,048,500
+611,600
+25% +$26.2M 0.05% 405
2025
Q3
$138M Buy
2,436,900
+890,900
+58% +$45.6M 0.08% 301
2025
Q2
$77.1M Buy
1,546,000
+388,700
+34% +$17.6M 0.05% 405
2025
Q1
$34.2M Buy
1,157,300
+191,600
+20% +$7.12M 0.03% 650
2024
Q4
$23.4M Buy
965,700
+674,500
+232% +$16.7M 0.02% 945
2024
Q3
$5.36M Buy
291,200
+131,200
+82% +$2.35M ﹤0.01% 1894
2024
Q2
$3.23M Buy
+160,000
New +$2.66M ﹤0.01% 2212

Other funds holding HIMS

David Shaw's HIMS Position: Q2 2026 in Review

David Shaw reduced its Hims & Hers Health (HIMS) stake by 71% in Q2 2026, selling an estimated $11.4M and leaving 171,530 shares worth $5.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2260.

David Shaw first reported a position in HIMS in Q2 2021 and has held it in 20 quarters since. The position peaked at $178M in Q1 2025. 504 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • David Shaw held 171,530 shares of Hims & Hers Health worth $5.95M as of Q2 2026.
  • David Shaw sold 423,338 Hims & Hers Health shares in Q2 2026, an estimated $11.4M.
  • Hims & Hers Health made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2260 holding.
  • David Shaw first reported a position in Hims & Hers Health in Q2 2021 and has held it in 20 quarters since.
  • David Shaw's Hims & Hers Health position peaked at $178M in Q1 2025.
  • 504 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.